InsiderTrades.com logo

ZVRA Insider Trading

Insider Ownership Percentage: 2.40%
Insider Buying (Last 12 Months): $152,485.25
Insider Selling (Last 12 Months): $885,165.78

Zevra Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Zevra Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Zevra Therapeutics Share Price & Price History

Current Price: $8.66
Price Change: ▼ Price Decrease of -0.06 (-0.69%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for ZVRA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Zevra Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/10/2025Neil F. McFarlaneCEOSell19,500$10.82$210,990.00222,016View SEC Filing Icon  
9/12/2025Tamara A FavoritoDirectorBuy3,175$7.79$24,733.253,894View SEC Filing Icon  
8/19/2025John B. BodeDirectorBuy5,000$9.16$45,800.0045,000View SEC Filing Icon  
3/28/2025Corey Michael WattonDirectorBuy300$7.84$2,352.001,800View SEC Filing Icon  
3/19/2025John B. BodeDirectorBuy10,000$7.96$79,600.0040,000View SEC Filing Icon  
2/13/2025Joshua SchaferEVPSell10,500$7.86$82,530.0029,486View SEC Filing Icon  
2/13/2025Neil F. McFarlaneCEOSell61,273$7.86$481,605.78222,060View SEC Filing Icon  
2/13/2025R. LaDuane CliftonCFOSell11,000$7.86$86,460.0051,361View SEC Filing Icon  
2/13/2025Timothy J. SangiovanniSVPSell3,000$7.86$23,580.0016,341View SEC Filing Icon  
10/11/2024Corey Michael WattonDirectorBuy500$7.92$3,960.001,500View SEC Filing Icon  
7/17/2024R. LaDuane CliftonCFOBuy2,000$6.77$13,540.0018,469View SEC Filing Icon  
7/16/2024Thomas AndersonDirectorBuy10,000$6.81$68,100.0020,000View SEC Filing Icon  
7/12/2024John B. BodeDirectorBuy10,000$5.87$58,700.0030,000View SEC Filing Icon  
9/6/2023R. LaDuane CliftonCFOBuy1,000$4.96$4,960.0015,309View SEC Filing Icon  
9/5/2023John B. BodeDirectorBuy10,000$5.13$51,300.0020,000View SEC Filing Icon  
9/5/2023Joshua SchaferEVPBuy500$5.13$2,565.003,500View SEC Filing Icon  
6/23/2023Corey Michael WattonDirectorBuy275$5.95$1,636.251,000View SEC Filing Icon  
6/9/2023Corey Michael WattonDirectorBuy325$5.52$1,794.00725View SEC Filing Icon  
5/30/2023Corey Michael WattonDirectorBuy400$5.11$2,044.00400View SEC Filing Icon  
5/19/2023Joshua SchaferEVPBuy1,000$5.42$5,420.003,000View SEC Filing Icon  
5/18/2023John B. BodeDirectorBuy10,000$5.04$50,400.0010,000View SEC Filing Icon  
5/18/2023R. LaDuane CliftonCFOBuy2,740$4.95$13,563.0013,742View SEC Filing Icon  
3/17/2023Tamara A SeymourDirectorBuy519$4.82$2,501.58719View SEC Filing Icon  
3/14/2023Joshua SchaferEVPBuy2,000$4.61$9,220.002,000View SEC Filing Icon  
3/10/2023R. LaDuane CliftonCFOBuy1,725$4.15$7,158.7511,002View SEC Filing Icon  
3/10/2023Timothy J. SangiovanniSVPBuy1,200$4.14$4,968.004,449View SEC Filing Icon  
3/9/2023Matthew R PloosterDirectorBuy11,000$4.20$46,200.0018,500View SEC Filing Icon  
3/9/2023Richard W PascoeCEOBuy10,000$4.20$42,000.0029,973View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Zevra Therapeutics (NASDAQ:ZVRA)

35.03% of Zevra Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ZVRA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Zevra Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/1/2025Cantor Fitzgerald L. P.117,576$1.12M0.0%+487.9%0.209%Search for SEC Filing on Google Icon
11/17/2025NewEdge Advisors LLC22,338$0.21M0.0%+458.5%0.040%Search for SEC Filing on Google Icon
11/17/2025Caxton Associates LLP17,317$0.17M0.0%N/A0.031%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP3,476,143$33.06M0.2%-24.7%6.175%Search for SEC Filing on Google Icon
11/17/2025PharVision Advisers LLC66,733$0.64M0.4%N/A0.119%Search for SEC Filing on Google Icon
11/17/2025XTX Topco Ltd66,381$0.63M0.0%N/A0.118%Search for SEC Filing on Google Icon
11/17/2025Verition Fund Management LLC193,509$1.84M0.0%N/A0.344%Search for SEC Filing on Google Icon
11/17/2025Polymer Capital Management US LLC31,698$0.30M0.0%+89.4%0.056%Search for SEC Filing on Google Icon
11/17/2025Quarry LP10,883$0.10M0.0%N/A0.019%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd306,489$2.92M0.0%+2,615.2%0.544%Search for SEC Filing on Google Icon
11/17/2025Prelude Capital Management LLC15,600$0.15M0.0%N/A0.028%Search for SEC Filing on Google Icon
11/17/2025Nantahala Capital Management LLC1,971,936$18.75M0.7%+34.0%3.503%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC1,035,251$9.85M0.0%+63.1%1.839%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.24,896$0.24M0.0%-17.7%0.044%Search for SEC Filing on Google Icon
11/17/2025Integrated Wealth Concepts LLC15,081$0.14M0.0%N/A0.027%Search for SEC Filing on Google Icon
11/17/2025Kingdon Capital Management L.L.C.650,000$6.18M0.8%+44.4%1.155%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP130,751$1.24M0.0%N/A0.232%Search for SEC Filing on Google Icon
11/17/2025Cantor Fitzgerald L. P.117,576$1.12M0.0%+487.9%0.209%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE288,045$2.74M0.0%+28.7%0.512%Search for SEC Filing on Google Icon
11/17/2025Boothbay Fund Management LLC14,943$0.14M0.0%N/A0.027%Search for SEC Filing on Google Icon
11/17/2025Aquatic Capital Management LLC28,593$0.27M0.0%-11.5%0.051%Search for SEC Filing on Google Icon
11/17/2025Algert Global LLC418,550$3.98M0.1%N/A0.743%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.23,306$0.22M0.0%-13.4%0.041%Search for SEC Filing on Google Icon
11/14/2025Virtu Financial LLC62,740$0.60M0.0%N/A0.111%Search for SEC Filing on Google Icon
11/14/2025Man Group plc33,652$0.32M0.0%N/A0.060%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC268,077$2.55M0.0%N/A0.476%Search for SEC Filing on Google Icon
11/13/2025Marshall Wace LLP912,299$8.68M0.0%N/A1.620%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG218,096$2.07M0.0%+41.5%0.387%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets10,993$0.11M0.0%-74.4%0.020%Search for SEC Filing on Google Icon
11/13/2025Franklin Resources Inc.36,835$0.35M0.0%N/A0.065%Search for SEC Filing on Google Icon
11/13/2025Legal & General Group Plc1,053,399$10.02M0.0%+12.6%1.871%Search for SEC Filing on Google Icon
11/13/2025WINTON GROUP Ltd12,161$0.12M0.0%N/A0.022%Search for SEC Filing on Google Icon
11/13/2025Russell Investments Group Ltd.6,374$61K0.0%+235.7%0.011%Search for SEC Filing on Google Icon
11/13/2025DLD Asset Management LP40,000$0.38M0.0%N/A0.071%Search for SEC Filing on Google Icon
11/13/2025Schroder Investment Management Group412,547$3.94M0.0%+30.8%0.733%Search for SEC Filing on Google Icon
11/12/2025Barclays PLC332,443$3.16M0.0%+218.6%0.591%Search for SEC Filing on Google Icon
11/12/2025Royce & Associates LP691,239$6.57M0.1%N/A1.228%Search for SEC Filing on Google Icon
11/12/2025Rafferty Asset Management LLC11,879$0.11M0.0%N/A0.021%Search for SEC Filing on Google Icon
11/12/2025Quantbot Technologies LP62,646$0.60M0.0%+116.1%0.111%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC20,895$0.20M0.0%-18.4%0.037%Search for SEC Filing on Google Icon
11/12/2025Fox Run Management L.L.C.31,021$0.30M0.0%+175.7%0.055%Search for SEC Filing on Google Icon
11/10/2025China Universal Asset Management Co. Ltd.9,840$94K0.0%-10.4%0.017%Search for SEC Filing on Google Icon
11/10/2025Kovack Advisors Inc.175,283$1.67M0.2%+19.4%0.311%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP54,397$0.52M0.0%N/A0.097%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.3,083,362$29.32M0.0%+4.4%5.493%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.438,984$4.18M0.0%+1,458.8%0.782%Search for SEC Filing on Google Icon
11/6/2025Rhumbline Advisers77,489$0.74M0.0%-6.9%0.138%Search for SEC Filing on Google Icon
11/6/2025Stratos Wealth Partners LTD.229,000$2.18M0.0%+4.1%0.408%Search for SEC Filing on Google Icon
11/6/2025Profund Advisors LLC17,190$0.16M0.0%N/A0.031%Search for SEC Filing on Google Icon
11/6/2025ProShare Advisors LLC11,279$0.11M0.0%-14.4%0.020%Search for SEC Filing on Google Icon
11/3/2025Retirement Planning Co of New England Inc.600,770$5.71M2.3%+8.6%1.070%Search for SEC Filing on Google Icon
11/3/2025Federated Hermes Inc.19,914$0.19M0.0%+2,316.7%0.035%Search for SEC Filing on Google Icon
10/31/2025Stoneridge Investment Partners LLC21,129$0.20M0.1%N/A0.038%Search for SEC Filing on Google Icon
10/28/2025Campbell & CO Investment Adviser LLC37,631$0.36M0.0%-54.8%0.067%Search for SEC Filing on Google Icon
10/15/2025CWM LLC2,872$27K0.0%+399.5%0.005%Search for SEC Filing on Google Icon
10/9/2025Voya Investment Management LLC10,334$98K0.0%-34.1%0.018%Search for SEC Filing on Google Icon
8/15/2025Tower Research Capital LLC TRC 9,937$88K0.0%+617.5%0.018%Search for SEC Filing on Google Icon
8/15/2025Rubric Capital Management LP1,958,318$17.25M0.3%+60.8%3.489%Search for SEC Filing on Google Icon
8/15/2025BNP Paribas Financial Markets42,950$0.38M0.0%+1,240.5%0.077%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE223,852$1.97M0.0%+150.4%0.399%Search for SEC Filing on Google Icon
8/15/2025683 Capital Management LLC1,125,000$9.91M0.7%-8.2%2.004%Search for SEC Filing on Google Icon
8/15/2025Adage Capital Partners GP L.L.C.4,168,000$36.72M0.1%+15.2%7.426%Search for SEC Filing on Google Icon
8/14/2025Occudo Quantitative Strategies LP14,138$0.13M0.0%N/A0.026%Search for SEC Filing on Google Icon
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.30,260$0.27M0.0%-4.7%0.055%Search for SEC Filing on Google Icon
8/14/2025The Manufacturers Life Insurance Company 20,294$0.18M0.0%+9.4%0.037%Search for SEC Filing on Google Icon
8/14/2025Velan Capital Investment Management LP715,000$6.30M6.2%+7.5%1.308%Search for SEC Filing on Google Icon
8/14/2025Qube Research & Technologies Ltd11,288$99K0.0%N/A0.021%Search for SEC Filing on Google Icon
8/13/2025Stonepine Capital Management LLC775,620$6.83M6.7%+19.3%1.418%Search for SEC Filing on Google Icon
8/13/2025Quantbot Technologies LP28,992$0.26M0.0%N/A0.053%Search for SEC Filing on Google Icon
8/13/2025Schroder Investment Management Group315,469$2.78M0.0%N/A0.577%Search for SEC Filing on Google Icon
8/12/2025Ameritas Investment Partners Inc.5,541$49K0.0%+30.0%0.010%Search for SEC Filing on Google Icon
8/12/2025Rhumbline Advisers83,221$0.73M0.0%+11.6%0.152%Search for SEC Filing on Google Icon
8/12/2025Legal & General Group Plc935,677$8.24M0.0%+26.8%1.711%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.28,161$0.25M0.0%-3.4%0.052%Search for SEC Filing on Google Icon
8/8/2025Creative Planning10,453$92K0.0%N/A0.019%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC1,242,386$10.95M0.0%+0.8%2.272%Search for SEC Filing on Google Icon
8/7/2025Simplify Asset Management Inc.147,000$1.30M0.1%+22.5%0.269%Search for SEC Filing on Google Icon
8/7/2025ProShare Advisors LLC13,171$0.12M0.0%-6.1%0.024%Search for SEC Filing on Google Icon
8/7/2025Campbell & CO Investment Adviser LLC83,245$0.73M0.0%N/A0.152%Search for SEC Filing on Google Icon
8/7/2025Los Angeles Capital Management LLC121,225$1.07M0.0%N/A0.222%Search for SEC Filing on Google Icon
8/6/2025Fox Run Management L.L.C.11,251$99K0.0%N/A0.021%Search for SEC Filing on Google Icon
8/5/2025Corton Capital Inc.17,671$0.16M0.2%N/A0.032%Search for SEC Filing on Google Icon
8/4/2025Carret Asset Management LLC39,640$0.35M0.0%+9.7%0.072%Search for SEC Filing on Google Icon
7/29/2025AIGH Capital Management LLC918,893$8.10M3.6%-36.1%1.680%Search for SEC Filing on Google Icon
7/29/2025Stratos Wealth Partners LTD.220,000$1.94M0.0%-29.0%0.402%Search for SEC Filing on Google Icon
7/17/2025Janney Montgomery Scott LLC256,664$2.26M0.0%-8.5%0.469%Search for SEC Filing on Google Icon
6/27/2025Goldman Sachs Group Inc.194,813$1.46M0.0%-22.1%0.356%Search for SEC Filing on Google Icon
5/29/2025Rhumbline Advisers74,585$0.56M0.0%+9.6%0.136%Search for SEC Filing on Google Icon
5/28/2025Strs Ohio16,700$0.13M0.0%N/A0.031%Search for SEC Filing on Google Icon
5/16/2025Woodline Partners LP4,615,625$34.57M0.2%+11.5%8.441%Search for SEC Filing on Google Icon
5/16/2025Arete Wealth Advisors LLC74,854$0.56M0.0%-4.0%0.137%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.194,813$1.46M0.0%-22.1%0.356%Search for SEC Filing on Google Icon
5/16/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.31,761$0.24M0.0%+6.1%0.058%Search for SEC Filing on Google Icon
5/16/2025Adage Capital Partners GP L.L.C.3,618,000$27.10M0.1%-0.9%6.617%Search for SEC Filing on Google Icon
5/15/2025Nantahala Capital Management LLC1,471,936$11.03M0.4%-37.1%2.692%Search for SEC Filing on Google Icon
5/15/2025Retirement Planning Co of New England Inc.550,180$4.12M1.5%+6.9%1.006%Search for SEC Filing on Google Icon
5/15/2025Velan Capital Investment Management LP665,000$4.98M5.1%+121.7%1.216%Search for SEC Filing on Google Icon
5/14/2025Stonepine Capital Management LLC650,000$4.87M4.7%+8.8%1.189%Search for SEC Filing on Google Icon
5/14/2025EntryPoint Capital LLC40,675$0.31M0.1%+53.8%0.074%Search for SEC Filing on Google Icon
5/14/2025Wellington Management Group LLP140,418$1.05M0.0%N/A0.257%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Zevra Therapeutics logo
Zevra Therapeutics, Inc. discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company develops its products through Ligand Activated Therapy platform. Its lead product candidate is KP1077, consisting of KP1077IH, which is under Phase 2 clinical trial for the treatment of idiopathic hypersomnia, and KP1077N, which is under Phase ½ clinical trial to treat narcolepsy. The company is also developing Celiprolol, a prodrug product candidate that is under Phase 1/2 clinical trial for the treatment of vascular Ehlers Danlos syndrome. In addition, it offers AZSTARYS, a once-daily treatment for attention deficit hyperactivity disorder in patients aged six years and older; OLPRUVA to treat urea cycle disorders; and Arimoclomol for the treatment of niemann pick disease type C, an ultra-rare neurodegenerative lysosomal storage disorder. The company has collaboration and license agreement with Commave Therapeutics SA to develop, manufacture and commercialize the company's product candidates containing SDX and d-methylphenidate; and license agreement with Acer and Relief Therapeutics, Inc. to develop and commercialize rights for OLPRUVA. The company was formerly known as KemPharm, Inc. and changed its name to Zevra Therapeutics, Inc. in February 2023. Zevra Therapeutics, Inc. was incorporated in 2006 and is headquartered in Celebration, Florida.
Read More on Zevra Therapeutics

Today's Range

Now: $8.66
Low: $8.48
High: $8.80

50 Day Range

MA: $9.79
Low: $8.17
High: $11.78

52 Week Range

Now: $8.66
Low: $6.19
High: $13.16

Volume

823,188 shs

Average Volume

1,395,027 shs

Market Capitalization

$487.56 million

P/E Ratio

18.43

Dividend Yield

N/A

Beta

1.01

Who are the company insiders with the largest holdings of Zevra Therapeutics?

Zevra Therapeutics' top insider investors include:
  1. Neil F Mcfarlane (CEO)
  2. R Laduane Clifton (CFO)
  3. John B Bode (Director)
  4. Joshua Schafer (EVP)
  5. Thomas Anderson (Director)
  6. Timothy J Sangiovanni (SVP)
  7. Tamara A Favorito (Director)
  8. Corey Michael Watton (Director)
Learn More about top insider investors at Zevra Therapeutics.

Who are the major institutional investors of Zevra Therapeutics?

Zevra Therapeutics' top institutional shareholders include:
  1. Woodline Partners LP — 6.17%
  2. Vanguard Group Inc. — 5.49%
  3. Nantahala Capital Management LLC — 3.50%
  4. Legal & General Group Plc — 1.87%
  5. Millennium Management LLC — 1.84%
  6. Caption Management LLC — 0.00%
Learn More about top institutional investors of Zevra Therapeutics stock.

Which institutional investors are selling Zevra Therapeutics stock?

Within the previous quarter, ZVRA stock was sold by these institutional investors:
  1. Woodline Partners LP
  2. Susquehanna International Group LLP
  3. Campbell & CO Investment Adviser LLC
  4. BNP Paribas Financial Markets
  5. Rhumbline Advisers
  6. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
  7. Voya Investment Management LLC
  8. Intech Investment Management LLC
In the previous year, company insiders that have sold Zevra Therapeutics company stock include:
  1. Neil F Mcfarlane (CEO)
  2. R Laduane Clifton (CFO)
  3. John B Bode (Director)
  4. Joshua Schafer (EVP)
Learn More investors selling Zevra Therapeutics stock.

Which institutional investors are buying Zevra Therapeutics stock?

During the previous quarter, ZVRA stock was bought by institutional investors including:
  1. Marshall Wace LLP
  2. Caption Management LLC
  3. Royce & Associates LP
  4. Nantahala Capital Management LLC
  5. Algert Global LLC
  6. JPMorgan Chase & Co.
  7. Millennium Management LLC
  8. Qube Research & Technologies Ltd
In the previous year, these company insiders have bought Zevra Therapeutics stock:
  1. Neil F Mcfarlane (CEO)
  2. R Laduane Clifton (CFO)
  3. John B Bode (Director)
  4. Joshua Schafer (EVP)
  5. Thomas Anderson (Director)
Learn More investors buying Zevra Therapeutics stock.